ISEC Healthcare reported FY2025 revenue of SGD 79.2 million (+7%) and profit for the year of SGD 13.4 million (+4%), with basic EPS of 2.32 cents (+4%). For 2H2025, revenue was SGD 41.4 million (+7%) and profit was SGD 6.5 million (+5%). As at 31 Dec 2025, cash and cash equivalents were SGD 23.8 million, total assets were SGD 145.8 million and net asset value per share was SGD 0.18. By segment for FY2025, specialised health services revenue was SGD 75.3 million and segment profit after tax was SGD 12.8 million, while general health services revenue was SGD 3.9 million and segment profit after tax was SGD 0.6 million. The group recorded no goodwill impairment loss in FY2025; the prior year’s other expenses included an impairment loss for goodwill of SGD 1.5 million. In corporate updates, ISEC Healthcare issued 507,500 ordinary shares in May 2025 at SGD 0.350 per share under its performance share plan, increasing issued shares to 575,700,552, and it reported equity dilution in its ISEC Klang subsidiary following a new shareholder subscription during the period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ISEC Healthcare Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: D6OE9QB81NI62XRO) on February 26, 2026, and is solely responsible for the information contained therein.